Effect of cisplatin on triple negative breast cancer /

Effect of cisplatin on triple negative breast cancer /

Show other versions (1)

Bibliographic Details
Main Author:	Hend Salaheldien Ahmed Elnour, 1986-, author 611422
Format:	text
Language:	eng
Published:	Johor Bahru, Johor : Universiti Teknologi Malaysia, 2017
Subjects:	Cisplatin Breast

Similar Items

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422, et al.
Published: (2017)

The effects of cisplatin in triple negative breast cancer cells /
by: Farah Sahira Mohd Khalil, 1993- , author 609191
Published: (2016)

The effects of cisplatin in triple negative breast cancer cells /
by: Farah Sahira Mohd Khalil, 1993- , author 609191, et al.
Published: (2016)

Effects of Newcastle disease virus infection on cisplatin-resistant breast cancer cell line
by: Jamal, Mohd Hafifi
Published: (2015)

Effects of combined cisplatin and clinacanthus nutans on gene expression of MDA-MB-231 breast cancer cells /
by: Yeo, Zhin Leng, 1994-, author 614715
Published: (2018)

Effects of combined cisplatin and clinacanthus nutans on gene expression of MDA-MB-231 breast cancer cells /
by: Yeo, Zhin Leng, 1994-, author 614715, et al.
Published: (2018)

Effects of cisplatin in cervical cancer cells /
by: Siti Khairunnisa Ishak, 1993-, author 609192
Published: (2016)

Effects of cisplatin in cervical cancer cells /
by: Siti Khairunnisa Ishak, 1993-, author 609192, et al.
Published: (2016)

The anticancer effects of curcumin on triple-negative breast cancer cells /
by: Nur Arifah Husin Basri, 1994-, author 620226
Published: (2017)

The anticancer effects of curcumin on triple-negative breast cancer cells /
by: Nur Arifah Husin Basri, 1994-, author 620226, et al.
Published: (2017)

The effects of bismuth oxide nanoparticles and cisplatin on MCF-7 breast cancer cells irradiated with Ir-192 High Dose Rate brachytherapy
by: Noor Nabilah Talik Sisin, et al.
Published: (2022-03-01)

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours
by: Jiyoung Park, et al.
Published: (2013-04-01)

Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers
by: Mai G. Awad, et al.
Published: (2024-11-01)

Potential therapeutic effect of thymoquinone on cisplatin-induced hepatotoxicity in rats
by: Sercan Kaya, et al.
Published: (2024-03-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer
by: Marwa Mohanad, et al.
Published: (2025-02-01)

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin
by: Keita Sekine, et al.
Published: (2024-11-01)

Paving the way for better ototoxicity assessments in cisplatin therapy using more reliable animal models
by: Vijayprakash Manickam, et al.
Published: (2025-03-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis
by: Alia Khalil, et al.
Published: (2025-01-01)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
by: Lili Zhao, et al.
Published: (2019-05-01)

Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer
by: Takahiro Kimura, et al.
Published: (2018-02-01)

Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment
by: Hanan Seddiek, et al.
Published: (2025-02-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Cytotoxicity of natural and synthetic cannabinoids and their synergistic antiproliferative effects with cisplatin in human ovarian cancer cells
by: Ying Chen, et al.
Published: (2024-11-01)

Cisplatin‐coordinated copolythiophene for synergistic chemotherapy and sonodynamic therapy of tumor
by: Yuanyu Tang, et al.
Published: (2024-09-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

EFFECT OF CISPLATIN ON HEMOSTASIS IN EXPERIMENTAL ANIMALS
by: M. V. Filonova, et al.
Published: (2020-07-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Cisplatin-Induced Renal Failure Measured by Glomerular Filtration Rate (GFR) with <sup>99</sup>mTc-DTPA Scans in Cancer Patients: A Systematic Review and Meta-Analysis
by: Mansour M. Alqahtani
Published: (2024-11-01)

Prostate neuroendocrine carcinoma successfully treated with etoposide and cisplatin
by: Masanori Ishizaki, et al.
Published: (2024-11-01)

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
by: Yuhan Liu, et al.
Published: (2024-11-01)

Cisplatin and dexamethasone separate and combined effect on nephrotoxic processes in female rats
by: Zhenya Yavroyan, et al.
Published: (2024-11-01)

Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
by: Hassan Bardania, et al.
Published: (2024-11-01)

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin
by: Pieter Spincemaille, et al.
Published: (2014-10-01)

Targeting a cell state common to triple‐negative breast cancers
by: Markus K Muellner, et al.
Published: (2015-02-01)

DLAT promotes triple-negative breast cancer progression via YAP1 activation
by: Diya Liu, et al.
Published: (2024-12-01)

Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer
by: Xiangying Meng, et al.
Published: (2013-05-01)

Role of zinc oxide nanoparticles supplementation on alleviate side effects of cisplatin induced cardiotoxicity in rats
by: A. M. Al-lbban
Published: (2025-02-01)